Product
AC-OLE-01-VA
2 clinical trials
1 indication
Indication
Alzheimer's diseaseClinical trial
A Phase 1, Open-label Study to Evaluate the Tolerability of 21 Days of Treatment With the AC-OLE-01-VA Formulation of Tricaprilin Under Different Dosing Conditions in Healthy ParticipantsStatus: Completed, Estimated PCD: 2022-12-22
Clinical trial
A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin, and Matching Placebo to Include Single-dose and Food Effect (Part A), and Titration Tolerability (Part B), in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-08-13